Article information
Resumo
A patologia respiratória é relativamente frequente durante a gravidez. Um terço das grávidas sofrem exacerbação da asma. O tromboembolismo pulmonar é cerca de 5 vezes mais frequente na gravidez. As pneumonias bacte-rianas, virais e fúngicas são mal toleradas pela grávida, provocando significativa morbilidade materno-fetal, insuficiência respiratória, baixo peso ao nascer ou prema-turidade. A tuberculose, se não for tratada, pode aumentar em 4 vezes a mortalidade materna e em 9 vezes o parto pré-termo. A gravidez está contra-indicada em mulheres com fibrose quística e função pulmonar grave. Apesar dos progressos terapêuticos, a hipertensão pulmonar continua a estar associada a valores superiores a 30% de morbilidade e mortalidade materno-fetal. Apro-ximadamente 1 em 1000-1500 gravidezes é complicada por neoplasia maligna materna. O cancro do pulmão nas grávidas coloca desafios terapêuticos importantes devido às elevadas taxas de mortalidade.
Rev Port Pneumol 2007; XIII (2): 213-238
Palavras-chave:
Pulmão
gravidez
alterações fisioló-gicas
complicações pulmonares
Abstract
Respiratory pathology can be relatively frequent during pregnancy. One third of pregnant woman may experience worsening of their asthma condition. Pulmonary tromboembolism is 5 times more frequent in pregnancy. Bacterial, viral and fungal pneumonias are baddly tolerated during pregnancy, provoking mother-foetal morbidity, respiratory insufficiency, low born-weight or prematurity. Non-treated tuberculosis may increase maternal mortality and preterm birth by 4 and 9 times respectively. Pregnancy is counter-indicated in women with cystic fibrosis and severe pulmonary function. Despite therapeutic progresses already made, pulmonary hypertension is associated to over 30% of mother-foetal morbidity and mortality. Approximately 1 in 1,000-1,500 pregnancies is affected by mother cancer. High rates of lung cancer morbility in women bring new and important challenges to therapy.
Rev Port Pneumol 2007; XIII (2): 213-238
Key-words:
Pregnancy
lung
physiological changes
pulmonary complications
Full text is only aviable in PDF
Bibliografia
[1.]
S.H. Soubra, K.K. Guntupalli.
Critical illness in pregnancy: An overview.
Crit Care Med, 33 (2005), pp. S248-S255
[3.]
E.R. Yeomans, C. Gilstrap III.
Physiologic Changes in pregnancy and their impact on critical care.
Crit Care Med, 33 (2005), pp. S256-S258
[4.]
F. Cunningham, N. Gant, K. Leveno, L. Gilstrap, J. Hauth, K. Wenstrom.
Section XII: Medical and Surgical complications in pregnancy.
Williams Obstetrics, 21, pp. 1224-1244
[5.]
K. Spiropoulos, E. Prodromaki, V. Tsapanos.
Effect of Body Position on PaO2 and PaCO2 during pregnancy.
Gynecologic and Obstetric Investigation, 58 (2004),
[6.]
Sat Sharma.
Pulmonary disease and pregnancy.
[7.]
R.A. Wise, A.J. Polito, V. Krishnan.
Respiratory physiologic changes in pregnancy.
Immunol Allergy Clin North Am, 26 (2006), pp. 1-12
[8.]
K. Spiropoulos, E. Prodromaki, V. Tsapanos.
Effect of body position on PaO2 and PaCO2 during pregnancy.
Gynecologic and Obstetric Investigation, 58 (2004),
[9.]
A. Bier, J.C. Virchow.
Pneumological Disease in Pregnancy.
MMW Fortschr Med, 147 (2005), pp. 32-33
[10.]
E. Murphy, P.G. Gibson, R. Smith, V.L. Clifton.
Asthma during pregnancy: mechanisms and treatment implication.
Eur Respir Journ, 25 (2005), pp. 731-750
[11.]
National Asthma Education and Prevention Program Asthma Pregnancy.
Managing Asthma During Pregnancy: Recommendations for Pharmacologic Treatment, (2004),
[12.]
V.E. Murphy, V.L. Clifton, P.G. Gibson.
Asthma exacer-bations during pregnancy: incidence and association with adverse pregnancy outcomes.
Thorax, 61 (2006), pp. 169-176
[13.]
G. Brum.
Gravidez-complicações pulmonares.
39.º Curso de Pneumologia para pós-graduados, pp. 145-151
[14.]
M.G. Freitas, R. Amaral Marques, P. Ponce.
Asma brôn-quica.
Manual de Terapêutica Médica, pp. 45-54
[15.]
S.M. Bates, J.S. Ginsberg.
How we manage venous thromboembolism during pregnancy.
Blood, 100 (2002), pp. 3470-3478
[16.]
A.F. Scarsbrook, A.L. Evans, A.R. Owen, F.V. Gleeson.
Diagnosis of suspected venous thromboembolic disease in pregnancy.
Clin Radiol, 61 (2006), pp. 1-12
[17.]
M. Lisa, L.B. Kathry, M. Susan.
MSc. Sex and gender issues and venous thromboembolism.
Clin Chest Med, 25 (2004), pp. 281-297
[18.]
S. Stone, T.A. Morris.
Pulmonary embolism during and after pregnancy.
Crit Care Med, 33 (2005), pp. S294-S299
[19.]
J.T. Monteiro.
Tromboembolismo pulmonar: Aspectos particulares, pp. 115-117
[20.]
T.E. Nolan, R.P. Smith, L.D. Devoe.
Maternal plasma D-dimer levels in normal and complicated pregnancy.
Obstet Gynecol, 81 (1993), pp. 235-238
[21.]
L.K. Tan, M. Swiet.
Management of thromboembolic disease in pregnancy.
Ann Acad Med Singapore, 31 (2002), pp. 311-319
[22.]
E.L. Palmer, J.A. Scott, H.W. Strauss.
Practical Nuclear Medicine,
[23.]
Goldhaber SZ. Pulmonary Embolism. Medical Progress. 339(2):93-104
[24.]
E. Trukhacheva, M. Scharff, M. Gardner, N. Lakkis.
Massive pulmonary embolism in pregnancy treated with tissue plasminogen activator.
Obstet Gynecol, 106 (2005), pp. 1156-1158
[25.]
J. Moore, M.R. Baldisseri.
Amniotic fluid embolism.
Crit Care Med, 33 (2005), pp. S279-S284
[26.]
B.M. Marie, A.C. Arroliga, S. Emery.
Exacerbation of underlying pulmonary disease in pregnancy.
Crit Care Med, 33 (2005), pp. 313-314
[27.]
Martins Correia J. Hipertensão Pulmonar. In: Maria João Marques Gomes, R Sotto-Mayor (eds): Tratado de Pneumologia. Vol II. SPP. pp. 1599-626
[28.]
D. Bendayan, M. Hold, G. Oron, A. Sagie, L. Eidelman, D. Shitrit, M.R. Kramer.
Pregnancy outcome in patients with pulmonary arterial hypertension Receiving prosta-cyclin therapy.
Obstetrics and Gynecology, 106 (2005),
[29.]
A.C. Mendes.
Doenças vasculares do pulmão, pp. 115-117
[30.]
C.A. Elliot, P. Stewart, V.J. Webster, G.H. Mills, S.P. Hutchinson, E.S. Howarth, F.A. Bu’lock, R.A. Lawson, I.J. Arms-trong, D.G. Kiely.
The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension.
Eur Respir Journ, 26 (2005), pp. 168-173
[31.]
Carro-Jiménez EJ, Lopez JE. Primary pulmonary hypertension and pregnancy. Bol Assoc Med PR 97(4):328-33
[32.]
I. Bildirici, J.B. Shumway.
Intravenous and Inhaled Epoprostenol for primary pulmonary hypertension during pregnancy and delivery.
Obstetrics and Gynecology, 103 (2004),
[33.]
B.M. Weiss, O.M. Hess.
Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives.
Eur Heart J, 21 (2000), pp. 104-115
[34.]
C. Geohas, V.V. McLaughlin.
Successful Management of Pregnancy in a Patient with Eisenmerger Syndrome With Epoprostenol.
Chest, 124 (2003), pp. 1170-1173
[35.]
R.J. Barst, L.J. Rubin, W.A. Long, S. Rich, et al.
A comparison of continuous intravenous Epoprostenol with conventional therapy for primary pulmonary hypertension.
N Eng J Med, 334 (1996), pp. 22-301
[36.]
D.E. Cole, T.L. Taylor, D.M. McCullough, C.T. Shoff, S. Derdak.
Acute respiratory distress syndrome in pregnancy.
Crit Care Med, 33 (2005), pp. S269-S276
[37.]
S. Fatimi, S. Sheikh, S.F. Khan.
Arterio-venous malformation of the lung in pregnancy with massive haemoptysis.
IJTCVS, 21 (2005), pp. 281-282
[38.]
P.S. Ramsey, K.D. Ramin.
Pneumonia in pregnancy.
Obstet Gynecol Clin North Am, 28 (2001),
[39.]
W.S. Lim, J.T. Macfarlane, C.L. Colthorpe.
Treatment of community-acquired lower respiratory tract infections during pregnancy.
Am J Respir Med, 2 (2003), pp. 221-233
[40.]
U. Munnur, B. Boisblanc, M.S. Suresh.
Airway problems in pregnancy.
Crit Care Med, 33 (2005), pp. S259-S267
[41.]
J.W. Ely, Y. Jerome, B. Noelle.
Evaluation of Pregnant Womem Exposed to Respiratory Virus, (2000),
[42.]
L.J. Wheat.
Systemic Fungal Infection During Pregnancy.
Case Study, (2005),
[43.]
F. Aoki, Y. Sando, S. Tajima, K. Imai, T. Hosono, T. Maeno, T. Suga, J. Sugano, Y. Shitara, M. Kurabayashi.
Invasive Pulmonary Aspergillosis in a Puerperant with Drug induced Agranulocytosis.
Intern Med, 40 (2001), pp. 1128-1131
[44.]
A. Manique.
Tuberculose na Mulher – Aspectos particulares, pp. 153-162
[45.]
Stop Tuberculosis Guidelines for Social Mobilization.
A Human Rights Approach to Tuberculosis,
[46.]
J.T.I. Good, P.T. Davidson, et al.
Tuberculosis in association with pregnancy.
Am J Obstet Gynecol, 140 (1981), pp. 492
[47.]
V.K. Arora, R. Gupta.
Tuberculosis and Pregnancy.
Indian Journal of Tuberculosis, 50 (2003), pp. 13
[48.]
F. Antunes.
Programa Nacional da Luta Contra a Tuberculose.
Sistema de Vigilância. Ponto de situação epi-demiológica e de desempenho, pp. 1-12
[49.]
Medir para mudar, pp. 126-136
[50.]
Hans L. Rieder.
Bases epidemiológicas do controlo da tuberculose.
Direcção Geral de Saúde, (2001),
[51.]
Manual de Pneumologia.
Sociedade Brasileira PT.
Pneumopatias na gestação:, (2002), pp. 371-378
[52.]
M.F. Telhada.
Quimioterapia antituberculosa.
Tratado de Pneumologia, pp. 711-764
[53.]
Pestana E, Pina J. A Tuberculose em grupos epide-miológicos Particulares. Tuberculose na Viragem do Milénio. Lidel – Edicões Técnicas, Lda. pp. 501-503
[54.]
N.O. Toure, Y. Dia, A. Diatta, C.M. Ndiaye, B.A. Sah, A. Niang, N. Fall, M. Kane, F. Mbaye, A. Cisse, A.A. Hane.
Preliminary study of the association of tuberculosis and pregnancy: about 9 cases.
Dakar Med, 49 (2004), pp. 192-195
[55.]
M.C. Gomes, M.G. Freitas, P. Ponce.
Tuberculose pulmonar e extra pulmonar.
Manual de Terapêutica Médica, pp. 12-21
[56.]
TB is single biggest killer of young women.
(1998),
[57.]
Treatment of tuberculosis: Guidelines for National Programme: WHO/CDS/TB 2003, World Health Organization, (2003), pp. 313
[58.]
Treatment of tuberculosis.
Am J Respir Crit Med, 167 (2003), pp. 603-662
[59.]
British HIV Association Guidelines for TB/HIV infection. Feb 2005
[60.]
Centers for Diseases Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep, 54 (2005), pp. 249-250
[61.]
P. Azevedo.
Fibrose Quística.
Abordagem do adulto, pp. 115-117
[62.]
E. Stuart.
Pregnancy and Cystic Fibrosis.
Cystic Fibrosis Trust, (2002),
[63.]
P.M. Connors, M.M. Ulles.
The psychological and social implications of caring for the pregnant patient and newborn with cystic fibrosis.
J Perinat Neonatal Nurs, 19 (2005), pp. 301-315
[64.]
I. Odegaard, B. Stray-Pedersen, K. Hallberg, O.C. Haanaes, O.T. Storrosten, M. Johannesson.
Prevalence and outcome of pregnancy in Norwegian and Swedish Women with cystic fibrosis.
Acta Obstet Gynecol Scand, 81 (2002), pp. 693-697
[65.]
A.H. Mc Mullen, D.J. Pasta, P.D. Frederick, M.W. Konstan, W.J. Morgan, M.S. Schechter, J.S. Wagener.
Impact of pregnancy on women with cystic fibrosis.
Chest, 129 (2006), pp. 706-711
[66.]
J.R. Yankaskas, B.C. Marshall, J.D. Sulfian, R.H. Simon, D. Rodman.
Cystic Fibrosis Adult Care.
Chest, 125 (2004), pp. 1S-39S
[67.]
B. Asher, M. Dulitzki, O. Efrati, A. Augarten, A. Szein-berg, N. Reichert, D. Modan, B. Weiss, M. Miller, D. Katza-nelson, Y. Yahav.
Pregnancies and Outcome in Women with Cystic Fibrosis.
Is Med Assoc J, 7 (2005), pp. 95-98
[68.]
C.H. Goss, G.D. Rubenfeld, K. Otto, M.L. Aitken.
The effect of pregnancy on survival in women with cystic fibrosis.
Chest, 124 (2003), pp. 460-468
[69.]
J. Prenaut, P. Audra, C. Mossan, P. Gaucherand.
Cystic Fibrosis and pregnancy: report of twin pregnancy and review of the literature.
J Gynecol Obstet Biol Reprod (Paris), 34 (2005), pp. 716-720
[70.]
C.H. Goss, G.D. Rubenfeld, K. Otto, M.L. Aitken.
The effect of pregnancy on survival in women with cystic fibrosis.
Chest, 124 (2003), pp. 1460-1467
[71.]
A.J. Cameron, T.A. Skinner.
Management of parturient with respiratory failure secondary to cystic fibrosis.
Anaestesia, 60 (2005), pp. 77-80
[72.]
Y. Martinet, A. Bohadana, S. Toussaint, N. Wirth, C. Thévenin, O. Tabagismo.
O tabagismo, da dependência à abstinência. Climepsi Editores, 5 (2003), pp. 193-216
[73.]
N.L. Benowitz, D.A. Dempsey.
Pharmacotherapy for smoking cessation during pregnancy.
Nicotine e Tabacco Research, 6 (2004), pp. S189-S202
[74.]
T.L. Petty.
Why women are more susceptible; how treatment should differ.
The Rising Epidemic of COPD in Women. Women’s Health in Primary Care, 2 (1999), pp. 942-953
[75.]
B.J. Fu, Y.T. Kau, R.K. Severson, G.P. Kalemkerian.
Lung cancer in women. Analysis of the national Surveillance, Epidemiology, and End Results database.
Chest, 127 (2005),
[76.]
A. Jemal, A. Thomas, T. Murray, et al.
Cancer statistics.
CA Cancer J Clin, 52 (2002), pp. 23-47
[77.]
C. Jackisch, L. Frank, A. Schwenkhagen, K. Brigitta, K.W. Schimid, P.G. Schneider, H. Wolfgang.
Lung Cancer during pregnancy involving the products of conception and a review of the literature.
Arch Gynecol Obstet, 268 (2003), pp. 69-77
[78.]
J.M. Walker, J.F. Reinisch, H.L. Monforte.
Maternal pulmonary adenocarcinoma metastatic to the fetus: first recorded case report and literature review.
Pediatr Pathol Mol Med, 21 (2002), pp. 57-69
[79.]
M. Teksam, A. McKinney, J. Short, S.O. Casey, C.L. Truwit.
Intracranial metastasis via transplacental (vertical) transmission of maternal small cell lung cancer to fetus: CT and MRI findings.
Acta Radiol, 45 (2004), pp. 577-579
[80.]
P.A. Janne, D. Rodriguez Thompson, D.R. Metcalf, S.J. Swanson, H.A. Greisman, L.W. Haug, B.E. Johnson.
Chemotherapy for a patient with advanced non-small-cell lung cancer during pregnancy: a case report and a review of chemotherapy treatment during pregnancy.
Oncology, 61 (2001), pp. 175-183
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
Pulmonology
- Home
- All contents
- Publish your article
- About the journal
- Metrics
- Open access
Article options